Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CANOMICS

Financiado

Cerrado

Multicentre discovery of breast cancer biomarkers

Breast cancer is the most common cause of death from cancer among European women, and over half of the worldwide breast cancer related mortalities occur in the developing world. Despite improvements in surgical techniques and chem... ver más

31/07/2012

SOUTHAMPTON

86K€

Presupuesto del proyecto: 86K€

Líder del proyecto

UNIVERSITY OF SOUTHAMPTON No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 3 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2012-07-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

3 Participantes

SOUTHAMPTON

0.00€ | Lider

BIOMEDICAL RESEARCH FOUNDATI...

N.D. | Participante

ST GEORGES HOSPITAL MEDICAL...

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PROTBIOFLUID PROTEOMIC IDENTIFICATION OF BIOMARKERS IN BIOFLUIDS AND IN P... 355K€ Cerrado

CTCPROTEOMIC Single cell proteomics for studying circulating tumor cells... 200K€ Cerrado

PLEC2021-007892 Plataforma (Oncodeeplasm) para inmunoensayos optoplasmónicos... 336K€ Cerrado

ENDOPREDICT Protein biomarker for the prediction of response to endocrin... 570K€ Cerrado

CANDLE Cancer Diagnosis by Multiplex Protein Epitope Profiling 71K€ Cerrado

DPI2015-68982-R MEDICINA PROTEOGENOMICA EN CANCER: IDENTIFICACION Y DETECCIO... 118K€ Cerrado

Líder del proyecto

UNIVERSITY OF SOUTHAMPTON No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 86K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Breast cancer is the most common cause of death from cancer among European women, and over half of the worldwide breast cancer related mortalities occur in the developing world. Despite improvements in surgical techniques and chemoradiotherapy, the ability to cure patients with breast cancer remains limited and five year survival for patients with advanced disease is dismal. Expression profiling and biomarker discovery aims to provide means for tumour diagnosis, classification, and prediction of response to therapy and prognosis. This could potentially lead to the building of robust early detection modules, and personalised effective breast cancer therapies which would improve outcomes. The emerging field of proteomics targets the discovery of early stage biomarkers in biological tissue which could lead to new clinically valid biomarkers discovery.The goal of this application is to develop proteomic tests using different approaches for identification of breast cancer biomarkers which could ultimately form the basis of a screening and/or prognostication test. Using different biological samples and proteomic biomarkers’ discovery methods improves the prospects of classification and stratification of different biological groups. Early cancer detection, improved treatment selection and outcome are expected in return. This project is focused on early detection where comparative analysis of proteomes of normal individuals and patients with cancer, as well as different subgroups of patients, will be used to develop a signature of changes that are characteristic of breast cancer. Our study will be based on serum and breast tissue samples collected and analysed in 5 centres.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores